Universal Maritime Solutions (Unimed) has announced the acquisition of Elssi Maritime Services (Elssi), a Greece and Cyprus-based provider of drug and alcohol testing to the maritime industry.

The provider of medical and compliance solutions is backed by ZCG Private Equity, the private equity arm of ZCG, and follows Unimed’s integration of Lagaay Medical Group, a global distributor of pharmaceutical products and medical devices.

“This acquisition further expands Unimed’s global platform, enabling us to deliver greater value to clients wherever they operate,” said Søren Andersen, chief executive officer of Unimed.

Unimed said in a press release that the acquisition is its fourth under ZCG ownership.

Adam Pan, chief revenue officer of Unimed, said: “Elssi’s testing expertise enhances our ability to provide a comprehensive suite of innovative health and safety solutions and deepens our relationships with vessel operators worldwide.”

“We look forward to welcoming the talented Elssi team and, together, setting a new benchmark for operational excellence across the global maritime sector,” Pan added.

Founded in 1993, Elssi also offers a suite of testing capabilities, including drinking water analysis and benzene testing.

Unimed added that it will integrate Elssi’s offerings into its technology platform, enabling clients to access compliance tools, reporting and health services through a single digital experience. The combined company serves more than 18,000 vessels.

“Joining the Unimed family represents an exciting next chapter,” said Panagiotis Stamatopoulos of Elssi, who joins Unimed as a managing director to continue leading Elssi’s growth.

“Together we can extend our industry-leading testing services to Unimed’s global client base while also offering our existing customers an unparalleled suite of integrated solutions that can enhance health and safety standards across the maritime sector,” added Stamatopoulos.

Image: Søren Andersen